The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new program, called the Substance Access Beneficiary Engagement Incentive, is ...
Big news for seniors: A new Medicare program will cover popular GLP-1 weight-loss drugs like Wegovy starting July 2026. Learn ...
The Trump administration decided to put the pilot on hold until at least 2027.
Andwell Health Partners is among nearly 400 organizations selected nationwide to participate in the new Medicare GUIDE Model. The program will support people living with dementia and their caregivers ...